Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001576280-25-000213

Co-Chief Executive Officer sold 100,000 shares at an average $50.88 ($5,087,630)

  • Co-Chief Executive Officer gave up 14,603 shares (to pay taxes)
  • Co-Chief Executive Officer acquired 28,812 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Talasaz AmirAli · Co-Chief Executive Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-30 Exercise or conversion : show line 1 in the form 10b5-1 +4,815 2,074,271 D
2025-06-30 Shares withheld for taxes : show line 2 in the form 10b5-1 −2,441 $52.04 $127,030 2,071,830 D
2025-07-01 Sale : show line 3 in the form 10b5-1 −72,068 $50.67 $3,651,794 1,999,762 D
2025-07-01 Sale : show line 4 in the form 10b5-1 −27,932 $51.40 $1,435,836 1,971,830 D
2025-07-01 Exercise or conversion : show line 5 in the form 10b5-1 +23,997 1,995,827 D
2025-07-01 Shares withheld for taxes : show line 6 in the form 10b5-1 −12,162 $50.71 $616,735 1,983,665 D
Open-market sales · 100,000 sh · avg $50.88 · $5,087,630

Table II: Derivative

2 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2025-06-30 Exercise or conversion : show line 7 in the form 10b5-1 Restricted Stock Units −4,815 $0.00 4,815 9,629 D
2025-07-01 Exercise or conversion : show line 8 in the form 10b5-1 Restricted Stock Units −23,997 $0.00 23,997 143,983 D
Loading xslF345X05/wk-form4_1751505523.xml…